HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

NYU Langone: Evidence Mounts for Alternate Origins of Alzheimer’s Disease Plaques

The field argued for decades that such plaques, containing the protein amyloid beta, built up outside of cells as a crucial first step toward the brain damage observed in Alzheimer’s disease.

New Study Reveals UltraSight & Sheba Medical Center Enable Novice Ultrasound Users to Obtain Accurate, Diagnostic Quality Cardiac Images

According to the results, UltraSight is effective at instructing novice medical professionals to acquire diagnostic quality exams in cardiac patients.

First Patients Enrolled in IMPACT II Study to Evaluate Attune Medical’s ensoETM for Radiofrequency Ablation Procedures

The data from thE IMPACT II Study will be used in pursuit of expanding the ensoETM’s intended use to include reduction of esophageal thermal injury during cardiac radiofrequency ablation procedures.

Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial

REBALANCE-HF study is evaluating a novel frontline therapy called Splanchnic Ablation for Volume Management (SAVM) that aims to rebalance volume distribution in heart failure patients with preserved ejection fraction.

Vectorious Announces VECTOR-HF I Study Confirms Safety and Accuracy of V-LAP In-Heart Sensor for Left Atrial Pressure Management of Heart Failure

The V-LAP system is implanted permanently in the left atrial wall of the heart to remotely calculate left atrial pressure (LAP).

4C Medical Technologies Presents Data from the Global Clinical Experience for the AltaValve Early Feasibility Study at AATS 2022

Results from the AltaValve EFS show a 100% technical success rate from the first 10 patients treated via transapical (TA) approach globally.

Shockwave Medical Reports IVL Coronary Studies Demonstrate Excellent PCI Outcomes in Both Women and Men at One Year

“As someone who is dedicating her career to addressing the needs of the most complex patients, I find these results very encouraging,” said Katherine Kunkel, MD, MSEd, FSCAI, an interventional cardiologist at Piedmont Heart Institute in Atlanta, Ga., one of the sites that participated in Disrupt CAD III.

Robocath R-Evolution Multicenter European Clinical Study on Robotic Coronary Angioplasty Update

The results will be presented in detail at a second dedicated session ‘Robotic PCI: Evolution or R-Evolution’ on Thursday May 19, in room 251 between 12:15 and 1:00 p.m. (CET). notes Robocath.

Study Confirms Pelvic Floor Patients Overwhelmingly Prefer “In-person” to “Virtual-only” for at Home Care

97% of patients with pelvic floor disorders preferred to receive in-person physical therapy at home, with only 3% favoring app-based care, and the majority of patients agreed that they “would not even seriously consider a virtual-only care option.”